Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of 81 vs 325mg of ASA in Treatment of BCVI: A Feasibility RCT

NCT06383650 is registered in ClinicalTrials.gov with London Health Sciences Centre as lead sponsor.

NCT NCT06383650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06383650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of 81 vs 325mg of ASA in Treatment of BCVI: A Feasibility RCT
Lead sponsor
London Health Sciences Centre
Phase
Phase 1
Overall status
Unknown status
Start date
June 30, 2024
Completion date
September 30, 2025
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

carotid artery injuries, traumatic injury, vertebral artery injury